Corporate Overview

Heron Therapeutics, Inc. (NASDAQ: HRTX) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by extending their duration of action. The Company's lead product, SUSTOL™ (formerly APF530), is being developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting. Heron Therapeutics received a Complete Response Letter to its SUSTOL™ New Drug Application (NDA) and is targeting a resubmission of the NDA to the U.S. Food and Drug Administration in the fourth quarter of 2014.

More>>

Stock Quote
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$9.16
Change (%) Stock is Up 0.03 (0.33%)
Volume117,109
Data as of 07/25/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Calendar of Events
July 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-2-112345
6789101112
13141516171819
20212223242526
27282930315152
Recent NewsMore >>
DateTitle 
06/30/14Heron Therapeutics, Inc. Closes Underwritten Offering of Common Stock
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jun. 30, 2014-- Heron Therapeutics, Inc. (NASDAQ: HRTX), a specialty pharmaceutical company, today announced closing of its underwritten public offering of 4,751,358 shares of common stock at a public offering price of $11.75 per share. As a component of the offering, in lieu of common stock, Heron Therapeutics, Inc. also offered and sold to certain existing large investors pre-funded warrants to purchase up to an a... 
Printer Friendly Version
06/25/14Heron Therapeutics, Inc. Announces Pricing of Underwritten Offering of Common Stock
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jun. 25, 2014-- Heron Therapeutics, Inc. (NASDAQ: HRTX), a specialty pharmaceutical company, today announced the pricing of an underwritten offering of 4,500,000 shares of its common stock, offered at a price of $11.75 per share. Heron Therapeutics, Inc. has granted the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock. As a component of the offering, in lieu of co... 
Printer Friendly Version
06/24/14Heron Therapeutics, Inc. Announces Proposed Underwritten Offering of Common Stock
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jun. 24, 2014-- Heron Therapeutics, Inc. (NASDAQ: HRTX), a specialty pharmaceutical company, today announced its intention to offer and sell shares of its common stock in an underwritten offering pursuant to its existing shelf registration. All of the shares in the proposed offering are to be sold by Heron Therapeutics, Inc. Jefferies LLC and Leerink Partners LLC are acting as joint book-runners for t... 
Printer Friendly Version
06/20/14Heron Therapeutics Set to Join Russell 3000 Index
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jun. 20, 2014-- Heron Therapeutics, Inc. (NASDAQ:HRTX), a specialty pharmaceutical company, announced today that it is set to join the broad-market Russell 3000 Index, as well as the Russell Global and Russell Micro-Cap Indexes when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, 2014, according to a preliminary list of additions posted on June 13, 2014 on www.ru... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.